| CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia H Frangoul, D Altshuler, MD Cappellini, YS Chen, J Domm, BK Eustace, ... New England Journal of Medicine 384 (3), 252-260, 2021 | 2235 | 2021 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 2028 | 2011 |
| Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies TW Ho, B Mishu, CY Li, CY Gao, DR Cornblath, JW Griffin, AK Asbury, ... Brain 118 (3), 597-605, 1995 | 1083 | 1995 |
| Campylobacter Species and Guillain-Barré Syndrome I Nachamkin, BM Allos, T Ho Clinical microbiology reviews 11 (3), 555-567, 1998 | 856 | 1998 |
| Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China GM McKhann, DR Cornblath, JW Griffin, TW Ho, CY Li, Z Jiang, HS Wu, ... Annals of neurology 33 (4), 333-342, 1993 | 855 | 1993 |
| Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a … TW Ho, MD Ferrari, DW Dodick, V Galet, J Kost, X Fan, H Leibensperger, ... The Lancet 372 (9656), 2115-2123, 2008 | 666 | 2008 |
| CGRP and its receptors provide new insights into migraine pathophysiology TW Ho, L Edvinsson, PJ Goadsby Nature Reviews Neurology 6 (10), 573-582, 2010 | 634 | 2010 |
| Acute motor axonal neuropathy: an antibody‐mediated attack on axolemma C Hafer‐Macko, ST Hsieh, TW Ho, K Sheikh, DR Cornblath, CY Li, ... Annals of Neurology: Official Journal of the American Neurological …, 1996 | 618 | 1996 |
| Pathology of the motor‐sensory axonal Guillain‐Barré syndrome JW Griffin, CY Li, TW Ho, M Tian, CY Gao, P Xue, B Mishu, DR Cornblath, ... Annals of neurology 39 (1), 17-28, 1996 | 592 | 1996 |
| Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine TW Ho, LK Mannix, X Fan, C Assaid, C Furtek, CJ Jones, CR Lines, ... Neurology 70 (16), 1304-1312, 2008 | 565 | 2008 |
| Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy CE Hafer‐Macko, KA Sheikh, CY Li, TW Ho, DR Cornblath, GM McKhann, ... Annals of Neurology: Official Journal of the American Neurological …, 1996 | 526 | 1996 |
| Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases JW Griffin, CY Li, TW Ho, P Xue, C Macko, CY Gao, C Yang, M Tian, ... Brain 118 (3), 577-595, 1995 | 517 | 1995 |
| Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome TW Ho, HJ Willison, I Nachamkin, CY Li, J Veitch, H Ung, GR Wang, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 416 | 1999 |
| Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome JW Griffin, CY Li, C Macko, TW Ho, ST Hsieh, P Xue, FA Wang, ... Journal of neurocytology 25 (1), 33-51, 1996 | 348 | 1996 |
| Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention TW Ho, KM Connor, Y Zhang, E Pearlman, J Koppenhaver, X Fan, ... Neurology 83 (11), 958-966, 2014 | 347 | 2014 |
| Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine DJ Hewitt, SK Aurora, DW Dodick, PJ Goadsby, Y Ge, R Bachman, ... Cephalalgia 31 (6), 712-722, 2011 | 307 | 2011 |
| Randomized, controlled trial of telcagepant for the acute treatment of migraine KM Connor, RE Shapiro, HC Diener, S Lucas, J Kost, X Fan, K Fei, ... Neurology 73 (12), 970-977, 2009 | 302 | 2009 |
| Macrophage systems in peripheral nerves. A review JW Griffin, R George, T Ho Journal of Neuropathology & Experimental Neurology 52 (6), 553-560, 1993 | 282 | 1993 |
| Safety and clinical activity of the programmed death-ligand 1 inhibitor durvalumab in combination with poly (ADP-ribose) polymerase inhibitor olaparib or vascular endothelial … JM Lee, A Cimino-Mathews, CJ Peer, A Zimmer, S Lipkowitz, ... Journal of Clinical Oncology 35 (19), 2193-2202, 2017 | 273 | 2017 |
| Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes DR Hodgson, BA Dougherty, Z Lai, A Fielding, L Grinsted, S Spencer, ... British journal of cancer 119 (11), 1401-1409, 2018 | 265 | 2018 |
